Folate and neural tube: A review;FOLATES ET TUBE NEURAL - REVUE DE LA LITTERATURE

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 26, Issue 6, 1997, Pages 576-584

  Aubard, Y ^a   Piver, P ^a   Chinchilla, A M ^a   Baudet, J H ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Folates; Neural tube

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; METHIONINE; VALPROIC ACID;

CHROMOSOME ABERRATION; DIABETES MELLITUS; DIET; EUROPE; FEMALE; FETUS; FOLIC ACID DEFICIENCY; HERITABILITY; HUMAN; HYPERTHERMIA; NEURAL TUBE DEFECT; PARASITE; PRIMARY PREVENTION; REVIEW; RISK FACTOR; SOCIOECONOMICS; UNITED STATES; ZINC DEFICIENCY;

ANIMALS; EUROPE; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; FOOD, FORTIFIED; HOMOCYSTEINE; HUMANS; METHIONINE; METHYLATION; NEURAL CREST; NEURAL TUBE DEFECTS; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; PREVALENCE; RISK FACTORS;

EID: 0030782423     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. EUROCAT - Report 6 : surveillance of congenital anomalies, 1980-1992. A EUROCAT working group, a European Community Project Eds. Brussels, 1993.
2. Droulle P, Didier F, Simon E, Benoit B, Pagliai F, Gillet JY. Système nerveux central et rachis. In Echographie des malformations fœtales. Gillet JY, Boog G, Dumez Y, Nisand I, Valette C. Paris, Vigot; 1993:42-84.
3. Vodovar V, Dufouil C, Decker F, Goujard J. Spina bifida et handicap de l'enfant. In Recherche et politique de santé. L'apport des registres de morbidité, Ducimetière P, Montaville B, Schaffer P, Spira N. Paris, Inserm; 1992:99-102.
4. Khoury MJ, Erickson JD, James LM. Etiologic heterogeneity of neural tube defects : clues from epidemiology. Am J Epidemiol 1982; 115:538-48.
5. Leck I. Causation on neural tube defects : clue from epidemiology. Br Med Bull 1974; 30:158-63.
6. Phillips OP, Elias S. Genetics and epidemiology of neural tube defects. In : Churchill Livingston Eds. Maternal serum screening for fetal genetic disorders. USA : Elias & Simpson. 1992:1-23.
7. Zhao Q, Behringer RR, De Crombrugghe B. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for Cart 1 homeobox gene. Nature Genetics, 1996, 13:275-83.
8. Renwick JH. Hypothesis : Anencephaly and spina bifida are usually preventable by avoidance of a specific but unidentified substance present in certain potato tubers. Br J Prev Soc Med 1972;26:67-88.
9. Kline BE, Von Elbe H, Dahle NA. Toxic effects of potato sprouts and solanine fed to pregnant rats. Proc Soc Exp Biol Med 1961;107:807-10.
10. Kurtzke JF, Goldberg ID, Kurland LT. The distribution of deaths from congenital malformations of the nervous system. Neurology 1973;23:483-96.
11. Bjerkedal T, Cziezal J, Goujard J, Kallen B, Mastroialova P, Nevin N, Oakley G Jr, Rpbert E. Valproic acid and spina bifida. Lancet 1982;2:1096.
12. Buamah PK, Russel M, Bates G, Ward AM, Skillen AW. Maternel zinc status : a determination of central nervous system malformations. Br J Obstet Gynecol 1984;91:788-90.
13. Windham GC, Edmonds LD. Current trends in the incidence of neural tube defects. Pediatrics 1982;70:333-7.
14. Warkany J. Teratogen update : hyperthermia. Teratology 1986;33:365-71.
15. Clarren SK, Smith DW, Harvey MH, Ward RH, Myrianthopoulos NC. Hyperthermia : a prospective evaluation of a possible teratogenic agent in man. J Pediatr 1979; 95:81-3.
16. Hibbard ED, Smithells RW Folic acid metabolism and human embryopathy. Lancet 1965;1:1254.
17. Smithells RW, Nevin NC, Seller MJ et al. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1983;1:1027-31.
18. Goujard J, Breart G. Le risque lié aux enquêtes méthodologiquement discutables : l'exemple de la vitaminothérapie pour la prévention des anomalies de fermeture du tube neural. Rev Epidem Santé Publ 1994;42:444-9.
19. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. Double-blind randomized controlled trial of folate treatment before conception to prevent recurrence of neural tube defects. Br Med J 1981;282:1509-11.
20. MRC Vitamin Study Research Group. Prevention of neural tube defects : Result of the medical Research Council Vitamin Study. Lancet 1991;2:131-7.
21. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. Primary prevention of neural tube defects with folic acid supplementation. Cuba experience. Prenat Diagn 1990; 10:149-52.
22. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurent neural tube defects. J Am Med Ass 1993;269:1257-61.
23. Mulinare J, Cordero JF, Erickson DJ, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. J Am Med Ass 1988;260:3141-5.
24. Milunsky A, Jick H, Jick SS et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. J Am Med Ass 1989;262:2847-52.
25. Bower C, Stanley FJ. Dietary folate as a risk factor for neural tube defects : evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-9.
26. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
27. Streegers-Theunissen RP. Folate metabolism and neural tube defects : a review. Eur J Obstet Gynecol Rep Bio 1995; 67:39-48.
28. Strelling MK. Transfer of folate to the fetus. Dev Med Child Neurol 1976;18:533-5.
29. Kelly TE. Teratogenicity of anticonvulsant drugs I : review of the literature. Am J Med Genet 1984;19:413-58.
30. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F. Anticonvulsants, folate levels and pregnancy outcome : a prospective study. Ann Neurol 1987;21:176-82
31. Meadow SR. Anticonvulsant drugs and congenital abnormalities (letter). Lancet 1968;2:1296.
32. Kelly D, Weir P, Reed B, Scott J. Effect of anticonvulsant drugs on the rate of folate catabolism in mice. J Clin Invest 1979;64:1089-96.
33. Perucca E. Clinical implications of hepatic microsomal enzyme induction by antiepileptic drugs. Pharmac Ther 1987;33:139-44.
34. Robert E, Guibaud P. Maternal valproic acid and congenital neural tube defects (letter). Lancet 1982;2:937.
35. Rosa FW. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-7.
36. Herbert V. Folate and neural tube defects. Nutr Today 1992; Nov: 30-3.
37. Waid NJ, Bower C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994;343:307.
38. Strauss RG, Bernstein R. Folic acid and dilantin antagonism in pregnancy. Obstet Gynecol 1974;44:345-8.
39. Quinn PB, Cremin FM, O'Sullivan VR, Hewedi FM, Bond RJ. The influence of dietary folate supplementation on the incidence of theratogenesis in zinc-deficient rats. Br J Nutr 1990;64:233-43.
40. Coelho CND, Weber JA, Klein NW, Daniels WG, Hoagland TA. Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J Nutr 1987;119: 1716-25.
41. Milunsky A. Congenital defects, folic acid, and homoebox genes. Lancet 1996;348:419-20.
42. Coelho CND, Klein NW. Methionine and neural tube closure in cultured rat embryos : morphological and biochemical analyses. Teratology 1990;42:437-51.
43. Shepard TH. Catalogue of teratogenic agents, 6th ed. Baltimore MD, The John Hopkins University Press, 1989.
44. DHHS PHS Recommandations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR 41/no. RR-14, Sept 11, 1992; 1-7.
45. Acide folique et grossesse. Société française de Pédiatrie Comité de nutrition. Arch Pediatr 1995;2:173-81.
46. Grimes DA. Unplanned pregnancies in the US. Obstet Gynecol 1986;67:438-42.
47. Clark NAC, Fisk NM. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br J Obstet Gynaecol 1994;101:709-10.
48. Federal Register, DHHS, FDA, 21 CFR Part 101 et al. Folic acid : Proposed rules, Oct 14, 1993.